secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001493152-25-021525
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera regains Nasdaq compliance on stockholders' equity and bid price rules
--------------------------------------------------------------------------------

- Received Nov 4 notice from Nasdaq confirming compliance with Rule 5550(b)(1) (stockholders' equity).
- Received Nov 6 notice confirming compliance with Rule 5550(a)(2) (minimum bid price ≥$1.00 for 11 consecutive days).
- Company previously disclosed deficiencies on May 21 and May 8, 2025 respectively.
- Nasdaq notes company may be subject to delisting if fails to evidence compliance upon next periodic report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315225021525/0001493152-25-021525-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315225021525/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-021525

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer